819 related articles for article (PubMed ID: 10638019)
1. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.
Gentilini P; Laffi G; La Villa G; Raggi VC
Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019
[TBL] [Abstract][Full Text] [Related]
2. Fluid retention in cirrhosis: pathophysiology and management.
Kashani A; Landaverde C; Medici V; Rossaro L
QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
[TBL] [Abstract][Full Text] [Related]
3. Update on ascites and hepatorenal syndrome.
Gentilini P; Vizzutti F; Gentilini A; Zipoli M; Foschi M; Romanelli RG
Dig Liver Dis; 2002 Aug; 34(8):592-605. PubMed ID: 12502217
[TBL] [Abstract][Full Text] [Related]
4. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS
Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521
[TBL] [Abstract][Full Text] [Related]
5. Hepatorenal syndrome.
Gattoni A; Marotta F; Vangieri B; Pisani G; Cristiano F
Clin Ter; 2004 Sep; 155(9):375-89. PubMed ID: 15700631
[TBL] [Abstract][Full Text] [Related]
6. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
7. Ascites and hepatorenal syndrome: pathogenesis and treatment strategies.
Ginès P; Arroyo V; Rodés J
Adv Intern Med; 1998; 43():99-142. PubMed ID: 9506180
[No Abstract] [Full Text] [Related]
8. Ascites in liver diseases.
Gentilini P; Laffi G
Ann Ital Med Int; 1991; 6(1 Pt 2):148-55. PubMed ID: 1742150
[TBL] [Abstract][Full Text] [Related]
9. Hepatorenal syndrome.
Biswas KD; Jain AK
Trop Gastroenterol; 2002; 23(3):113-6. PubMed ID: 12693150
[TBL] [Abstract][Full Text] [Related]
10. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.
Wong F; Raina N; Richardson R
Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of ascites in cirrhosis and portal hypertension.
Heneghan MA; Harrison PM
Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415
[TBL] [Abstract][Full Text] [Related]
13. Hepatorenal syndrome.
Bataller R; Arroyo V; Ginès P; Sort P
Forum (Genova); 1998; 8(1):62-81. PubMed ID: 9565447
[TBL] [Abstract][Full Text] [Related]
14. Review article: Management of ascites and associated complications in patients with cirrhosis.
Kuiper JJ; de Man RA; van Buuren HR
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():183-93. PubMed ID: 18081661
[TBL] [Abstract][Full Text] [Related]
15. Hepatorenal syndrome and its treatment today.
Gentilini P; La Villa G; Casini-Raggi V; Romanelli RG
Eur J Gastroenterol Hepatol; 1999 Sep; 11(9):1061-5. PubMed ID: 10503849
[TBL] [Abstract][Full Text] [Related]
16. [Natural course and physiopathology of ascites in the cirrhotic patient].
Bernardi M; Colantoni A; Caraceni P; Sica G; Trevisani F
Ann Ital Med Int; 1996 Oct; 11 Suppl 2():30S-38S. PubMed ID: 9004818
[TBL] [Abstract][Full Text] [Related]
17. [Hepatorenal syndrome].
Mijac D; Kezić A; Stojimirović B
Srp Arh Celok Lek; 2007; 135(1-2):98-104. PubMed ID: 17503577
[TBL] [Abstract][Full Text] [Related]
18. [Physiopathology of refractory ascites and the hepatorenal syndrome].
Arroyo V
Nefrologia; 2002; 22 Suppl 5():41-6. PubMed ID: 12107916
[No Abstract] [Full Text] [Related]
19. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
Wong F; Pantea L; Sniderman K
Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
[TBL] [Abstract][Full Text] [Related]
20. Refractory ascites: definition, pathogenesis and treatment.
Laffi G; La Villa G; Pinzani M; Foschi M; Carloni V; Casini Raggi V; Gentilini P
Ann Ital Med Int; 1993; 8(1):38-46. PubMed ID: 8485009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]